HDAC inhibitors target IRS4 to enhance anti-androgen receptor (AR) therapy in AR-positive triple negative breast cancer
收藏数据链接:
官方服务:
资源简介:
CAL51 cell lines were treated with Enz and Chid alone or in combination
创建时间:
2023-11-08

CAL51 cell lines were treated with Enz and Chid alone or in combination